(Q41353021)

29 September 2017

1 reference

title

Regulation of transcription of MHC class II genes (English)

1 reference

29 September 2017

Boss JM

1

1 reference

29 September 2017

1 February 1997

1 reference

Current Opinion in Immunology

29 September 2017

1 reference

29 September 2017

9

1 reference

29 September 2017

107-113

1 reference

29 September 2017

1

1 reference

Human class II major histocompatibility complex genes and proteins

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Class II transactivator regulates the expression of multiple genes involved in antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

The octamer motif is a B-lymphocyte-specific regulatory element of the HLA-DR alpha gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Transcription of HLA class II genes in the absence of B-cell-specific octamer-binding factor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

A B-cell coactivator of octamer-binding transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Binding and cooperative interactions between two B cell-specific transcriptional coactivators.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980166-5

7 January 2021

10.1016/S0952-7915(97)80166-5

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

9039770